Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov;6(6):1236-1242.
doi: 10.1002/mgg3.460. Epub 2018 Aug 27.

Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations

Devin M Cox  1 , Katherine L Nelson  1 , Meera Clytone  1 , Debra L Collins  1
Affiliations
Review

Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations

Devin M Cox et al. Mol Genet Genomic Med. 2018 Nov.

Abstract

Background: Historically, three founder mutations in the BRCA1/2 (OMIM 113705; OMIM 600185) genes have been the focus of cancer risks within the Ashkenazi Jewish (AJ) population. However, there are several additional mutations associated with increased susceptibility to cancer in individuals of AJ ancestry.

Methods: We report three patients who exemplify the need to keep these additional founder mutations in mind when pursuing hereditary cancer genetic testing of individuals in this population. All gene sequences in this paper were aligned to reference sequences based on human genome build GRCh37/UCSC hg19.

Results: review of the literature discusses that the combined risk is 12.36%-20.83% forhaving 1 of the 10 hereditary cancer AJ founder mutations in the BRCA1, BRCA2, CHEK2 (OMIM 604373), APC (OMIM 611731), MSH2 (OMIM 609309), MSH6 (OMIM 600678), and GREM1 (OMIM 603054) genes for individuals of AJ ancestry.

Conclusion: We recommend testing for all 10 of these AJ founder cancer susceptibility mutations for individuals within this population as standard screening in order to ensure appropriate cancer risk management and cascade testing.

Keywords: APC; BRCA1; BRCA2; CHEK2; GREM1; MSH2; MSH6; Ashkenazi; Jewish; breast cancer; cascade testing; colon cancer; founder mutations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigree of Patient 1. ¹Yr, ¹years; +², ²positive for pathogenic mutation
Figure 2
Figure 2
Pedigree of Patient 2. ¹Yr, ¹years; +², ²positive for pathogenic mutation
Figure 3
Figure 3
Pedigree of Patient 3. ¹Yr, ¹years; +², ²positive for pathogenic mutation; VUS³, ³variant of uncertain clinical significance
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bahar, A. Y. , Taylor, P. J. , Andrews, L. , Proos, A. , Burnett, L. , Tucker, K. , … Buckley, M. F. (2001). The frequency of founder mutations in the BRCA1, BRCA2 and APC genes in Australian Ashkenazi Jews: Implications for the generality of the U.S. population data. American Cancer Society, 92, 440–445. - PubMed
    1. Boursi, B. , Sella, T. , Liberman, E. , Shapira, S. , David, M. , Kazanov, D. , … Kraus, S. (2013). The APC p. I1307K polymorphism is a significant risk factor for CGC in average risk Ashkenazi Jews. European Journal of Cancer, 49, 3680–3685. 10.1016/j.ejca/2013.03.040 - DOI - PubMed
    1. Daly, M. B. , Pilarski, R. , Berry, M. , Buys, S. S. , Farmer, M. , Friedman, S. , … Darlow, S. National Comprehensive Cancer Network Guidelines (2018). Genetic / Familial High‐Risk Assessment: Breast and Ovarian (Version 1.2018). Retrieved from http://www.nccn.org/ Accessed May 14, 2018
    1. Ferla, R. , Calo, V. , Cascio, S. , Rinaldi, G. , Badalamenti, G. , Carreca, I. , … Russo, A. (2007). Founder mutations in BRCA1 and BRCA2 genes. Annals of Oncology, 18(6), vi93–vi96. 10.1093/annonc/mdm234 - DOI - PubMed
    1. Foulkes, W. D. , Thiffault, I. , Gruber, S. B. , Horwitz, M. , Hamel, N. , Lee, C. , … Ellis, N. A. (2002). The founder mutation MSH2*1906G>C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi jewish population. American Journal of Human Genetics, 71, 1395–1412. 10.1086/345075 - DOI - PMC - PubMed

LinkOut - more resources